Trademark: 97171526
Word
URZENA
Status
Pending
Status Code
731
Status Date
Thursday, February 1, 2024
Serial Number
97171526
Mark Type
4000
Filing Date
Tuesday, December 14, 2021
Published for Opposition
Tuesday, December 13, 2022

Trademark Owner History
TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders of the integumentary system, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, bacterial, viral, fungal, and parasitic infections, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation

Trademark Events
Feb 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 1, 2024
Sou Extension 2 Granted
Feb 1, 2024
Sou Extension 2 Filed
Feb 1, 2024
Sou Teas Extension Received
Aug 8, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 4, 2023
Sou Extension 1 Granted
Aug 4, 2023
Sou Extension 1 Filed
Aug 4, 2023
Sou Teas Extension Received
Feb 22, 2023
Teas Change Of Correspondence Received
Feb 22, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Feb 22, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 22, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Feb 7, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 13, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 13, 2022
Published For Opposition
Nov 23, 2022
Notification Of Notice Of Publication E-Mailed
Nov 7, 2022
Approved For Pub - Principal Register
Nov 7, 2022
Examiner's Amendment Entered
Nov 7, 2022
Notification Of Examiners Amendment E-Mailed
Nov 7, 2022
Examiners Amendment E-Mailed
Nov 7, 2022
Examiners Amendment -Written
Oct 18, 2022
Teas Change Of Correspondence Received
Oct 18, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Oct 18, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 18, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 29, 2022
Notification Of Non-Final Action E-Mailed
Sep 29, 2022
Non-Final Action E-Mailed
Sep 29, 2022
Non-Final Action Written
Sep 20, 2022
Assigned To Examiner
Dec 17, 2021
New Application Office Supplied Data Entered
Dec 17, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24